Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liraglutide-Conjugated Poly(methyl vinyl ether-<i>alt</i>-maleic acid)-Coated Core-Shell Upconversion Nanoparticles for Theranostics of Diabetes.

ACS applied materials & interfaces·2025
Same author

Escherichia marmotae: a multidrug-resistant opportunistic human pathogen - first clinical isolation in the Czech Republic.

Folia microbiologica·2025
Same author

Physiological Fatty Acid-Stimulated Insulin Secretion and Redox Signaling <i>Versus</i> Lipotoxicity.

Antioxidants & redox signaling·2025
Same author

Mitochondria to plasma membrane redox signaling is essential for fatty acid β-oxidation-driven insulin secretion.

Redox biology·2024
Same author

BCAA metabolism in pancreatic cancer affects lipid balance by regulating fatty acid import into mitochondria.

Cancer & metabolism·2024
Same author

Two mitochondrial DNA polymorphisms modulate cardiolipin binding and lead to synthetic lethality.

Nature communications·2024

Related Experiment Video

Updated: Jan 1, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.2K

2-Hydroxyglutarate in Cancer Cells.

Petr Ježek1

  • 1Department of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.

Antioxidants & Redox Signaling
|December 19, 2019
PubMed
Summary

Cancer cells exhibit altered metabolism, producing 2-hydroxyglutarate (2HG). This metabolite impacts gene expression and immune response, offering potential as a cancer progression marker.

Keywords:
2-hydroxyglutarateDNA and histone hypermethylationimmune systemisocitrate dehydrogenase 1 and 2metabolic markermetabolic reprogramming in cancertumor cross talk

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.0K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.1K

Related Experiment Videos

Last Updated: Jan 1, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.2K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.0K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.1K

Area of Science:

  • Biochemistry
  • Oncology
  • Immunology

Background:

  • Cancer cells maintain an undifferentiated, stem cell-like state, leading to metabolic, genetic, and epigenetic alterations.
  • Specific metabolites, such as 2-hydroxyglutarate (2HG), are implicated in cancer progression and tumor-immune cell interactions.
  • 2HG is associated with reprogrammed metabolism, oxidative stress, and dysregulated gene expression in various cancers, including glioma and leukemia.

Purpose of the Study:

  • To investigate the role of 2-hydroxyglutarate (2HG) enantiomers in cancer cell metabolism and epigenetic modifications.
  • To explore the potential of 2HG as a clinical marker for cancer progression and patient prognosis.
  • To understand the mechanisms by which 2HG influences tumor microenvironment and immune cell function.

Main Methods:

  • Analysis of 2HG enantiomer production in cancer cells, including those with IDH1/IDH2 mutations and wild-type.
  • Investigation of 2HG's impact on chromatin-modifying enzymes, HIF, and mTOR pathways.
  • Comparative analysis of 2HG levels in cancer cells versus non-cancer cells.

Main Results:

  • Mutations in IDH1 and IDH2 lead to elevated r-2HG concentrations, while other enzymes produce s-2HG.
  • Even wild-type IDH enzymes can generate intermediate 2HG levels in certain cancers like breast carcinoma.
  • 2HG was found to inhibit chromatin-modifying enzymes and interfere with key cellular pathways like HIF and mTOR.

Conclusions:

  • 2HG plays a significant role in cancerogenesis by altering metabolism, epigenetics, and gene expression.
  • Understanding cancer-specific metabolic details and epigenetic changes related to 2HG can lead to novel diagnostic strategies.
  • Further research into 2HG and associated molecular pathways may enable early cancer diagnostics, prognosis prediction, and monitoring of treatment response.